Svenska Cellulosa Ab Sca Class A · OMXSTO:SCA_A

Svenska Cellulosa Ab Sca Class A — SCA — Q1 2013 Earnings Presentation

12 slides from Svenska Cellulosa Ab Sca Class A's earnings presentation, Apr 29, 2013

  1. Slide 1: Interim Report 1 January – 31 March 2013

    Interim Report 1 January – 31 March 2013

  2. Slide 2: Q1 2013 Macro update

    Q1 2013 Macro update  Global economy  Weak Western Europe  Some growth in US  Good growth in Emerging markets  Tissue  Some growth in Europe and North America  Strong growth in Emerging markets  Personal Care  Good demand for incontinence products in Europe  Stable demand for baby diapers

  3. Slide 3: Summary

    Summary Q1 2013 vs Q1 2012  Sales growth 20%*  Hygiene business, 23%**  Higher volumes  Acquisitions  Strong growth in Emerging markets  Forest Products, ‐7%*  Lower prices including currency effects  Divestment  EBIT increased 25%***  Acquisitions  Cost savings  Higher volumes  Lower r

  4. Slide 4: Efficiency programs

    Efficiency programs  Hygiene business cost and productivity program  Achieved cost savings Q1 2013: SEK 160m  Annualized cost savings in Q1 2013: EUR 75m  Total annual cost savings of EUR 300m, full effect in 2015  Georgia‐Pacific synergies  Achieved cost savings Q1 2013: SEK 54m  Annualized

  5. Slide 5: Q1 2013 results

    Q1 2013 results SEK millions Q1 Q1 unless otherwise stated 2013 2012 Change, % Change, % Net sales 22,386 19,490 15 20 ** EBIT* 2,205 1,834 20 25 *** EBIT margin* (%) 9.8 9.4 Profit before tax* 1,941 1,503 29 34 *** Earnings per share (SEK) 1.59 1.73 Operating cash flow 1,862 1,778 5 Debt/Equity rat

  6. Slide 6: Q1 2013 vs. Q4 2012

    Q1 2013 vs. Q4 2012 Summary  Group  Sales decreased 3%*  EBIT decreased 6%**  Business areas  Personal Care, EBIT decreased 4%** • Seasonality effects  Tissue, EBIT decreased 10%** • Seasonality effects  Forest Products, EBIT decreased 19%*** • Lower prices • Negative currency effects • Capit

  7. Slide 7: Personal Care

    Personal Care Q1 2013 vs Q1 2012  Sales growth 6% (11%*) 6,604 6,241 6%  Incontinence products increased 8%*  Baby diapers increased 11%*  Feminine care increased 3%*  Emerging markets increased 18%* SALES SEKm Q1 2012 Q1 2013  EBIT increased 21%** (27%***) 810 668 21%**  Higher volumes  Low

  8. Slide 8: Tissue

    Tissue Q1 2013 vs Q1 2012 11,630 9,121 28%  Sales growth 28% (33%*)  Consumer tissue increased 35%*  AFH tissue increased 28%*  Emerging markets increased 17%* SALES SEKm Q1 2012 Q1 2013  EBIT increased by 34%** (40%***)  Acquisition 1,235 34%**  Higher volumes 925  Cost savings EBIT** SEKm

  9. Slide 9: Forest Products

    Forest Products Q1 2013 vs Q1 2012  Sales decreased 11% (‐7%*)  Publication papers, decreased sales 4,783 4,248 • Lower prices and divestment ‐11%  Solid‐wood products, decreased sales • Lower prices • Higher volumes  Kraftliner, decreased sales SALES SEKm Q1 2012 Q1 2013 • Lower volumes • Highe

  10. Slide 10: Summary

    Summary  Good sales growth and higher earnings for the hygiene businesses  Challenging market and currency situation for Forest Products  Efficiency programs delivering according to plan  Good cash flow generation  Divestments of former Georgia‐Pacific units approved by EU  Laakirchen divestme

  11. Slide 11: Q&A

    Q&A April 29, 2013 Interim Report Q1 2013 11

  12. Slide 12: Slide 12

SCA — Q1 2013 Earnings Presentation on 6ix